Research Study

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
Principal Investigator 
Michelle M. Mezei

Overview

Body Locations and Systems 
Brain and Nerves
ClinicalTrials.gov# 
NCT03920293
Status 
Closed for Recruitment
Study Start/End 
Dec 11, 2020
Locations 
Diamond Health Care Centre
Name/Title 
Deborah Kraus, Research Nurse
Phone 
604-875-4111 ext. 22950
Email Address 
deborah.kraus@vch.ca
Purpose of Study 

The  purpose of this study is to evaluate the safety and efficacy of the drug ravulizumab for the treatment of participants with generalized myasthenia gravis.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.